SV

Shoor Veer Singh

Director Director DIN 01852028
DIN 01852028 First appointment Jan 2009 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Shoor Veer Singh

Data last updated:

Shoor Veer Singh was a Director at Charak Pathology Lab & Diagnostic Center Private Limited (2009–2019) and Director at Kbs Financial Advisors Private Limited (from 2009). The companies operate in Healthcare.

DIN 01852028
Primary Designation Director
Industry Healthcare
First Appointment 21 Jan 2009
Oldest Company Age 17 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jan 20092009Active
Director01 Jun 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kbs Financial Advisors Private Limited
Charak Pathology Lab & Diagnostic Center Private Limited
Premium access

Shareholding and investment profile for Shoor Veer Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shoor Veer Singh

Shoor Veer Singh was first appointed on 21 Jan 2009 as Director at Charak Pathology Lab & Diagnostic Center Private Limited.

Shoor Veer Singh held 2 earlier board appointments: Charak Pathology Lab & Diagnostic Center Private Limited (Director, 21 Jan 2009 to 01 May 2019); Kbs Financial Advisors Private Limited (Director, from 01 Jun 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available